×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.

Become an Incathlab member and receive full access to its content!

You must be an Incathlab member to access videos without any restrictions. Register for free in one minute and access all services provided by Incathlab.You will also be able to log into Incathlab from your Facebook or twitter account by clicking on login on the top-right corner of Incathlab website.

Registration Login


Chapters (9)
Description
Date : Friday, October 13th 2017 from 12:30pm to 02pm (GMT+2)
Honolulu : Friday, October 13th 2017 from 12:30am to 02am (GMT-10)
San Francisco : Friday, October 13th 2017 from 03:30am to 05am (GMT-7)
New York : Friday, October 13th 2017 from 06:30am to 08am (GMT-4)
Buenos Aires : Friday, October 13th 2017 from 07:30am to 09am (GMT-3)
Reykjavik : Friday, October 13th 2017 from 10:30am to 12pm (GMT)
London / Dublin : Friday, October 13th 2017 from 11:30am to 01pm (GMT+1)
Paris / Berlin : Friday, October 13th 2017 from 12:30pm to 02pm (GMT+2)
Istanbul : Friday, October 13th 2017 from 01:30pm to 03pm (GMT+3)
Moscou / Dubaï : Friday, October 13th 2017 from 02:30pm to 04pm (GMT+4)
Bangkok : Friday, October 13th 2017 from 05:30pm to 07pm (GMT+7)
Shanghai : Friday, October 13th 2017 from 06:30pm to 08pm (GMT+8)
Tokyo : Friday, October 13th 2017 from 07:30pm to 09pm (GMT+9)
Sydney : Friday, October 13th 2017 from 09:30pm to 11pm (GMT+11)
Wellington : Friday, October 13th 2017 from 11:30pm to 01am (GMT+13)
Last update : 2018-06-26
Language(s) : English
Views : 36107

Program

12.30 Introduction
12.32 Overview of devices:
    ○ Veniti stent...

Program

12.30 Introduction
12.32 Overview of devices:
    ○ Veniti stent – Stephen Black
    ○ Wallstent – Olivier Hartung
    ○ IVUS – Peter Neglen
12.47 Case in box n°1: May-Thurner syndrome
Panel discussion
12.57 Case in box n°2: May-Thurner syndrome
Panel discussion
13.07 Acute DVT:
    ○ Goals and history of clot removal strategies – Yves Alimi
    ○ PMT - Stephen Black
13.25 Treatment of chronic lesions:
    ○ Recanalization – Olivier Hartung
13.33 Case in box n°3: Left femoro iliac vein recanalization and stenting
Panel discussion
13.41 Case in box n°4: Left femoro iliac vein recanalization and stenting
Panel discussion
13.55 Conclusion

Educational objectives

  • Diagnostic approach for patients with suspected ilio-femoral vein obstructions
  • Tips and Tricks for venous recanalization in patients with:
    • Acute DVT
    • May Thurner Syndrome
    • Chronic obstructions of the ilio-femoral vein system
  • Stent design, performance and available evidence
  • Value of Intravascular ultrasound (IVUS) for venous recanalizsation

Audience

  • Endovascular specialists (Vascular Surgeons, Interventional Radiologists, Angiologists and Interventional Cardiologists) interested and/or specialized in venous interventions
  • Referring physicians of patients with venous disease
Files (1)
Linked playlists (7)
Comments(13)
Join the Discussion
See previous comments (3)
  • Sharif Khashaba K. kindly improve the voice

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    • Vanessa R. How do you treat venous non thrombotic in stent restenosis

        Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
        Your browser doesn't have Flash, Silverlight or HTML5 support.


      • Gustavo R. In chronic oclusion how often did you see instent stenosis in Iliocaval Wallstent

        • Olivier H. in our experience on 162 patients with a median follow-up of 44 months, primary patency is 70% at 60 months and assisted primary patency 85%

        • Peter N. Using the Wallstent, the cumulative in-stent stenosis rate at 6 years is in non-thrombotic obstructions (NIVL) 1% and in postthrombotic obstructions approximately 10%. In-stent stenosis is then defined as being >50% lumen reduction. It is common to see some in-stent layering of

        Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
        Your browser doesn't have Flash, Silverlight or HTML5 support.


      • Jacobo N. What do you think is the best aproach to the lesion, popliteal or contralateral? Thanks

        • Olivier H. for chronic lesion, i prefer anterograde approach through the femoral or popliteal. Some teams favor internal jugular approach (must always be ready in case of IVC lesions)
          for acute lesions, it depends on the patency of the popliteal vein. If occluded, jugular or controlateral acess

        Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
        Your browser doesn't have Flash, Silverlight or HTML5 support.


      • Maria Fabrizia G. do you use the same strategy in presence of PE?

        • Olivier H. PE does not change the strategy but can make discuss the use of an IVC filter

        Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
        Your browser doesn't have Flash, Silverlight or HTML5 support.


      • bander A. what is he indications in case of non thrombotic iliac vein lesion ?

        • Olivier H. symptomatic and disabled patients C2-6, pelvic congestion syndrome

        • Peter N. I agree with Olivier, but wants to qualify it slightly. As we pointed out in the discussion, compression of the iliac veins are common in the asymptomatic population and possibly up to 30% have >50% stenosis with no symptoms! So there is a potential risk of overtreatment. In chronic venous disease of the lower limb, treatment of the outflow obstruction is indicated in patients with the C-class in CEAP being marked swelling (C3) and those with skin changes/ulcers (C4-C6). In addition, you have those patients with venous pain without skin changes or varicose veins, which can not be solely explained by the presence of reflux, if any. We use visual analogue scale (VAS) to evaluate that, considering VAS >5 being significant. As Olivier pointed out the symptoms have to affect the patients' quality of life.

        Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
        Your browser doesn't have Flash, Silverlight or HTML5 support.


      • Sandeep S. When using three stents, why is the middle stent placed last in iliofemoral venous intervention?

        Is there any algorithim to decide on when and not to stent across deep femoral vein?

          Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
          Your browser doesn't have Flash, Silverlight or HTML5 support.


        Thursday, September 13th 2012 from 05pm to 07pm (GMT+2)
        Honolulu : Thursday, September 13th 2012 from 05am to 07am (GMT-10)
        San Francisco : Thursday, September 13th 2012 from 08am to 10am (GMT-7)
        New York : Thursday, September 13th 2012 from 11am to 01pm (GMT-4)
        Buenos Aires : Thursday, September 13th 2012 from 12pm to 02pm (GMT-3)
        Reykjavik : Thursday, September 13th 2012 from 03pm to 05pm (GMT)
        London / Dublin : Thursday, September 13th 2012 from 04pm to 06pm (GMT+1)
        Paris / Berlin : Thursday, September 13th 2012 from 05pm to 07pm (GMT+2)
        Istanbul : Thursday, September 13th 2012 from 06pm to 08pm (GMT+3)
        Moscou / Dubaï : Thursday, September 13th 2012 from 07pm to 09pm (GMT+4)
        Bangkok : Thursday, September 13th 2012 from 10pm to 12am (GMT+7)
        Shanghai : Thursday, September 13th 2012 from 11pm to 01am (GMT+8)
        Tokyo : Friday, September 14th 2012 from 12am to 02am (GMT+9)
        Sydney : Friday, September 14th 2012 from 02am to 04am (GMT+11)
        Wellington : Friday, September 14th 2012 from 04am to 06am (GMT+13)

        Unmet clinical needs in BTK

        Share
        November 2015
        Honolulu : Wednesday, November 25th 2015 from 04am to 06am (GMT-10)
        San Francisco : Wednesday, November 25th 2015 from 06am to 08am (GMT-8)
        New York : Wednesday, November 25th 2015 from 09am to 11am (GMT-5)
        Buenos Aires : Wednesday, November 25th 2015 from 11am to 01pm (GMT-3)
        London / Dublin : Wednesday, November 25th 2015 from 02pm to 04pm (GMT)
        Paris / Berlin : Wednesday, November 25th 2015 from 03pm to 05pm (GMT+1)
        Istanbul : Wednesday, November 25th 2015 from 04pm to 06pm (GMT+2)
        Moscou / Dubaï : Wednesday, November 25th 2015 from 06pm to 08pm (GMT+4)
        Bangkok : Wednesday, November 25th 2015 from 09pm to 11pm (GMT+7)
        Shanghai : Wednesday, November 25th 2015 from 10pm to 12am (GMT+8)
        Tokyo : Wednesday, November 25th 2015 from 11pm to 01am (GMT+9)
        Sydney : Thursday, November 26th 2015 from 12am to 02am (GMT+10)
        Wellington : Thursday, November 26th 2015 from 02am to 04am (GMT+12)

        2nd live Websymposium on Venous Interventions

        Learn and debate with the experts

        Share
        May 2013
        Honolulu : Tuesday, May 28th 2013 from 04am to 07am (GMT-10)
        San Francisco : Tuesday, May 28th 2013 from 07am to 10am (GMT-7)
        New York : Tuesday, May 28th 2013 from 10am to 01pm (GMT-4)
        Buenos Aires : Tuesday, May 28th 2013 from 11am to 02pm (GMT-3)
        Reykjavik : Tuesday, May 28th 2013 from 02pm to 05pm (GMT)
        London / Dublin : Tuesday, May 28th 2013 from 03pm to 06pm (GMT+1)
        Paris / Berlin : Tuesday, May 28th 2013 from 04pm to 07pm (GMT+2)
        Istanbul : Tuesday, May 28th 2013 from 05pm to 08pm (GMT+3)
        Moscou / Dubaï : Tuesday, May 28th 2013 from 06pm to 09pm (GMT+4)
        Bangkok : Tuesday, May 28th 2013 from 09pm to 12am (GMT+7)
        Shanghai : Tuesday, May 28th 2013 from 10pm to 01am (GMT+8)
        Tokyo : Tuesday, May 28th 2013 from 11pm to 02am (GMT+9)
        Sydney : Wednesday, May 29th 2013 from 01am to 04am (GMT+11)
        Wellington : Wednesday, May 29th 2013 from 03am to 06am (GMT+13)

        Tailored protection device for selected patients during CAS: The role of proximal protection systems

        Milan time : from 04 pm to 07 pm

        Share
        October 2016
        Honolulu : Wednesday, October 19th 2016 from 12:30am to 02am (GMT-10)
        San Francisco : Wednesday, October 19th 2016 from 03:30am to 05am (GMT-7)
        New York : Wednesday, October 19th 2016 from 06:30am to 08am (GMT-4)
        Buenos Aires : Wednesday, October 19th 2016 from 07:30am to 09am (GMT-3)
        Reykjavik : Wednesday, October 19th 2016 from 10:30am to 12pm (GMT)
        London / Dublin : Wednesday, October 19th 2016 from 11:30am to 01pm (GMT+1)
        Paris / Berlin : Wednesday, October 19th 2016 from 12:30pm to 02pm (GMT+2)
        Istanbul : Wednesday, October 19th 2016 from 01:30pm to 03pm (GMT+3)
        Moscou / Dubaï : Wednesday, October 19th 2016 from 02:30pm to 04pm (GMT+4)
        Bangkok : Wednesday, October 19th 2016 from 05:30pm to 07pm (GMT+7)
        Shanghai : Wednesday, October 19th 2016 from 06:30pm to 08pm (GMT+8)
        Tokyo : Wednesday, October 19th 2016 from 07:30pm to 09pm (GMT+9)
        Sydney : Wednesday, October 19th 2016 from 09:30pm to 11pm (GMT+11)
        Wellington : Wednesday, October 19th 2016 from 11:30pm to 01am (GMT+13)

        Conquering complex femoropopliteal cases

        New techniques and clinical evidences

        Share
        Scroll Up